The use of polymeric carriers in formulations of therapeutic drug delivery
systems has gained widespread application, due to their advantage of being
biodegradable and biocompatible. Among the microparticulate systems, micros
pheres have a special importance since it is possible to target drugs and p
rovide controlled release. Diclofenac sodium (DS), is a potent drug in the
NSAID group having non-steroidal, anti-inflammatory properties, and is wide
ly used in the treatment of rheumatoid arthritis, osteoarthritis and ankylo
sing spondylitis. In this present study, it was aimed to prepare microspher
e formulations of DS using a natural biodegradable polymer as a carrier for
intraarticular administration to extend the duration period of the dosage
form in the knee joint. Microsphere formulations of DS which were prepared
were evaluated in vitro for particle size, yield value, encapsulation effic
iency, surface morphology, and in vitro drug release. Two appropriate formu
lations were selected for in vivo trials. For the in vivo studies, Techneti
um-99m labelled polyclonal human immunogammaglobulin (Tc-99m-HIG) was used
as the radiopharmaceutical to demonstrate arthritic lesions by gamma scinti
graphy. After the induction of arthritis in knee joints of rabbits, the rad
io-labelled microspheres loaded with DS were injected directly into the art
icular cavity and at specific time points gamma scintigrams were obtained t
o find the residence time of the microspheres in knee joints in order to de
termine the most suitable formulation.